Mesna and febrile neutropenia Patient Reports February 11, 2012

Mesna Side Effects Report #4648335-1
Mesna side effect was reported by a Consumer or non-health professional from on Apr 27, 2005. Male patient, 45 years of age, was diagnosed with sarcoma and was treated with Mesna. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemoglobin decreased, platelet count abnormal. Mesna dosage: unknown. During the same period patient was treated with EPIRUBICIN, IFOSFAMIDE. Patient was hospitalized. Patient recovered.

Mesna Side Effects Report #5472175-7
Mesna side effect was reported by a Physician from UNITED STATES on Sept 10, 2007. Female patient, 21 years of age, was diagnosed with burkitt's lymphoma, tumour lysis syndrome, prophylaxis of nausea and vomiting and was treated with Mesna. After drug was administered, patient experienced the following side effects: asthenia, b-cell lymphoma, back pain , caesarean section, diarrhoea, fatigue, febrile neutropenia, fibrosis. Mesna dosage: 360 MG/M2 (360 MG/M2, 1-5 DAYS) INTRAVENOUS (NOT OTHERWISE SPECIFIED). During the same period patient was treated with IFOSFAMIDE, DOXORUBICIN, CYTARABINE, ETOPOSIDE, ALLOPURINOL, ONDANSETRON, DEXAMETHASONE. Patient recovered.

Mesna Side Effects Report #5472181-2
Mesna side effect was reported by a Physician from UNITED STATES on Sept 10, 2007. Male patient was diagnosed with burkitt's lymphoma and was treated with Mesna. After drug was administered, patient experienced the following side effects: caesarean section, clostridium difficile colitis, congenital pneumonia, cyanosis neonatal, febrile neutropenia, neonatal respiratory distress syndrome, platelet count increased, premature baby. Mesna dosage: 360 MG/M2 (360 MG/M2, 1 IN 1 D) TRANSPLACENTAL. During the same period patient was treated with IFOSFAMIDE, DOXORUBICIN, CYTARABINE, ETOPOSIDE, ALLOPURINOL, ONDANSETRON, METHOTREXATE, DEXAMETHASONE. Patient was hospitalized. Patient recovered.